Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
19181 | 452 | 33.3 | 61% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
21 | 35063 | OSTEOPOROSIS//OSTEOPOROSIS INTERNATIONAL//BONE MINERAL DENSITY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DIETARY CA RESTRICTION | Author keyword | 1 | 100% | 0% | 2 |
2 | ZURICH OSTEOPOROSIS GRP | Address | 1 | 100% | 0% | 2 |
3 | 1 ALPHA HYDROXYVITAMIN D 3 | Author keyword | 1 | 27% | 1% | 4 |
4 | SERUM PTH | Author keyword | 1 | 33% | 0% | 2 |
5 | 1 25OH2VITAMIN D | Author keyword | 1 | 50% | 0% | 1 |
6 | BIOCHEMICAL MARKERS OF BONE REMODELLING | Author keyword | 1 | 50% | 0% | 1 |
7 | BONE ACTIVE DRUGS | Author keyword | 1 | 50% | 0% | 1 |
8 | CALCIUM INTESTINAL ABSORPTION | Author keyword | 1 | 50% | 0% | 1 |
9 | DIFFERENT CALCIUM INTAKE | Author keyword | 1 | 50% | 0% | 1 |
10 | ENDOCRINOL SEMPR | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DIETARY CA RESTRICTION | 1 | 100% | 0% | 2 | Search DIETARY+CA+RESTRICTION | Search DIETARY+CA+RESTRICTION |
2 | 1 ALPHA HYDROXYVITAMIN D 3 | 1 | 27% | 1% | 4 | Search 1+ALPHA+HYDROXYVITAMIN+D+3 | Search 1+ALPHA+HYDROXYVITAMIN+D+3 |
3 | SERUM PTH | 1 | 33% | 0% | 2 | Search SERUM+PTH | Search SERUM+PTH |
4 | 1 25OH2VITAMIN D | 1 | 50% | 0% | 1 | Search 1+25OH2VITAMIN+D | Search 1+25OH2VITAMIN+D |
5 | BIOCHEMICAL MARKERS OF BONE REMODELLING | 1 | 50% | 0% | 1 | Search BIOCHEMICAL+MARKERS+OF+BONE+REMODELLING | Search BIOCHEMICAL+MARKERS+OF+BONE+REMODELLING |
6 | BONE ACTIVE DRUGS | 1 | 50% | 0% | 1 | Search BONE+ACTIVE+DRUGS | Search BONE+ACTIVE+DRUGS |
7 | CALCIUM INTESTINAL ABSORPTION | 1 | 50% | 0% | 1 | Search CALCIUM+INTESTINAL+ABSORPTION | Search CALCIUM+INTESTINAL+ABSORPTION |
8 | DIFFERENT CALCIUM INTAKE | 1 | 50% | 0% | 1 | Search DIFFERENT+CALCIUM+INTAKE | Search DIFFERENT+CALCIUM+INTAKE |
9 | HYPOZINCAEMIA | 1 | 50% | 0% | 1 | Search HYPOZINCAEMIA | Search HYPOZINCAEMIA |
10 | NAPIIIA | 1 | 50% | 0% | 1 | Search NAPIIIA | Search NAPIIIA |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | POST MENOPAUSAL OSTEOPOROSIS | 12 | 31% | 7% | 33 |
2 | CIRCULATING FREE | 3 | 100% | 1% | 3 |
3 | SENILE OSTEOPOROSIS | 3 | 18% | 4% | 17 |
4 | INTESTINAL RESPONSIVENESS | 3 | 42% | 1% | 5 |
5 | 1 ALPHA HYDROXYVITAMIN D 3 | 3 | 35% | 1% | 6 |
6 | REGULATING HORMONES | 3 | 24% | 2% | 9 |
7 | IMMUNOREACTIVE PARATHYROID HORMONE | 1 | 19% | 2% | 7 |
8 | TOTAL 1 25 DIHYDROXYVITAMIN D | 1 | 100% | 0% | 2 |
9 | RENAL CALCIUM CONSERVATION | 1 | 40% | 0% | 2 |
10 | BIOCHEMICAL VARIABLES | 1 | 19% | 1% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Management of osteoporosis with calcitriol in elderly Chinese patients: a systematic review | 2014 | 1 | 21 | 33% |
Active vitamin D and its analogs as drugs for the treatment of osteoporosis: advantages and problems | 2002 | 8 | 15 | 67% |
The efficacy of calcitriol therapy in the management of bone loss and fractures: a qualitative review | 2010 | 9 | 109 | 30% |
Evolution of the Calcium Paradigm: The Relation between Vitamin D, Serum Calcium and Calcium Absorption | 2010 | 7 | 25 | 28% |
VITAMIN-D IN THE TREATMENT OF OSTEOPOROSIS | 1992 | 23 | 34 | 82% |
Vitamin D in the treatment of osteoporosis revisited | 1996 | 11 | 38 | 34% |
Improving the outcome of established therapies for osteoporosis by adding the active D-hormone analog alfacalcidol | 2007 | 8 | 41 | 15% |
Estrogens and bone disease in chronic kidney disease: role of FGF23 | 2010 | 5 | 49 | 14% |
Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol | 2004 | 16 | 59 | 22% |
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis | 2005 | 0 | 141 | 27% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ZURICH OSTEOPOROSIS GRP | 1 | 100% | 0.4% | 2 |
2 | ENDOCRINOL SEMPR | 1 | 50% | 0.2% | 1 |
3 | MALMO ALLMANNA SJUKHUS | 1 | 50% | 0.2% | 1 |
4 | METAB FUSHIMI KU | 1 | 50% | 0.2% | 1 |
5 | PUBL HLTH EPIDEMIOL HLTH ECON UNIT | 1 | 50% | 0.2% | 1 |
6 | SERV NEPHROL MINERVA CALCIUM BONE METAB | 1 | 50% | 0.2% | 1 |
7 | ZENTRUM KLIN CHEM | 1 | 50% | 0.2% | 1 |
8 | HLTH SCI SW MED SURG | 0 | 20% | 0.4% | 2 |
9 | BONE MINERAL UNITREDINREN ISCIII | 0 | 33% | 0.2% | 1 |
10 | CLIN REG BONE | 0 | 33% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000180522 | OSTEOPOROSIS INDUCTION//CHAIR SURG PATHOPHYSIOL//OST 6 OSTEOCARE |
2 | 0.0000176296 | CALCIUM INTAKE//CALCIUM ABSORPTION//CALCIUM BIOAVAILABILITY |
3 | 0.0000148686 | 24 25 DIHYDROXYVITAMIN D 3//25 HYDROXYVITAMIN D 24 HYDROXYLASE//24 25 DIHYDROXYVITAMIN D3 |
4 | 0.0000148400 | AROMATASE DEFICIENCY//MALE OSTEOPOROSIS//INTEGRATED MED ENDOCRINOL METAB GERIATR |
5 | 0.0000141386 | PTH ASSAYS//WHOLE PTH//INTACT PTH |
6 | 0.0000141369 | VITAMIN D//25 HYDROXYVITAMIN D//VITAMIN D DEFICIENCY |
7 | 0.0000117826 | ENDOMETRIAL SAFETY//TRIMEGESTONE//CAS 53 16 7 |
8 | 0.0000106617 | CALCITONIN//SALMON CALCITONIN//CALCITONIN RECEPTOR |
9 | 0.0000102400 | BONE FLUORIDE CONTENT//CAS 10163 15 2//MONOFLUOROPHOSPHATE |
10 | 0.0000100582 | DEOXYPYRIDINOLINE//PYRIDINOLINE//OSTEOCALCIN |